Showing results (171-180 of 214) with videos related to
Sort By:
Pageof 22
Journal of Medicinal Chemistry|November 1, 1990
Quinazoline antifolate thymidylate synthase inhibitors: benzoyl ring modifications in the C2-methyl seriesP R Marsham, A L Jackman, J Oldfield, et al.Journal of the Peripheral Nervous System : JPNS|November 2, 2016
Inhibition of complement in Guillain-Barré syndrome: the ICA-GBS studyAmy I Davidson, Susan K Halstead, John A Goodfellow, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study GroupD R Newell, A D Pearson, K Balmanno, et al.Journal of Medicinal Chemistry|July 1, 1991
Quinazoline antifolate thymidylate synthase inhibitors: bridge modifications and conformationally restricted analogues in the C2-methyl seriesP R Marsham, A L Jackman, A J Hayter, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Carboplatin dosage: prospective evaluation of a simple formula based on renal functionA H Calvert, D R Newell, L A Gumbrell, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2011
A phase I dose escalation study of AT9283, a small molecule inhibitor of aurora kinases, in patients with advanced solid malignanciesH-T Arkenau, R Plummer, L R Molife, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2023
Carboplatin dosage: prospective evaluation of a simple formula based on renal functionA H Calvert, D R Newell, L A Gumbrell, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2011
A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumorsD Mahadevan, R Plummer, M S Squires, et al.Advances in Experimental Medicine and Biology|January 1, 1993
Gamma-linked dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8- dideazafolate as antitumour agentsA L Jackman, G M Bisset, D I Jodrell, et al.Cancer Treatment Reports|January 1, 1985
Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancerI E Smith, S J Harland, B A Robinson, et al.Pageof 22